PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED

This adverse event was reported 73 times

These drugs are most commonly taken by patients reporting PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED:

# Drug Count
0 SORAFENIB 17
1 ATEZOLIZUMAB 8
2 BEVACIZUMAB 8
3 REGORAFENIB 8
4 DURVALUMAB 7
5 TREMELIMUMAB 6
6 CABOZANTINIB 5
7 LENVATINIB 5
8 RIVAROXABAN 5
9 APIXABAN 3
See all common drugs associated with PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED

PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CROTAMITON 1 0.0016
1 TREMELIMUMAB 6 0.0014
2 AMPICILLIN AND SULBACTAM 1 0.0011
3 SORAFENIB 17 0.0008
4 REGORAFENIB 8 0.0007
5 NIZATIDINE 1 0.0007
6 CEFACLOR 1 0.0006
7 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
8 IOPAMIDOL 1 0.0003
9 DURVALUMAB 7 0.0003
See all drugs enriched for association with PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED